Latest News

  • PSI Orion Infusion Limite ...
    Date : 25, Nov 2023
    ...
  • PRICE SENSITIVE INFORMATI ...
    Date : 25, Nov 2023
    ...
  • Proxy Form ...
    Date : 28, Nov 2021
    ...
  • PSI Q1 2021 ...
    Date : 16, Nov 2021
    ...
  • PSI and AGM, 2021 ...
    Date : 14, Nov 2021
    ...
  • Price Sensitive Informati ...
    Date : 1, Jul 2021
      ORION INFUSION LIMITED Registered Office:...
  • AGM and EGM Meeting Link- ...
    Date : 19, Dec 2020
    https://orioninfusion-agm-egm.bdvirtual.com...
  • NOTICE OF AN EXTRA-ORDINA ...
    Date : 5, Dec 2019
      ORION INFUSION LIMITED Registered Office: Orion Hou...
  • PSI_Press release_Q1_2019 ...
    Date : 13, Nov 2019
    ORION INFUSION LIMITED Register Office: Orion House, 153-1...
  • EGM Notice_OIL ...
    Date : 4, Nov 2019
    ORION INFUSION LIMITED Registered Office: Orion House, 153...
  • Price Sensitive Informati ...
    Date : 24, Oct 2019
    ORION INFUSION LIMITED Register Office: Orion House, 153-15...
  • UN-AUDITED HALF YEARLY (Q ...
    Date : 3, Feb 2019
    ORION INFUSION LIMITED Register Office: Orion Hou...
  • UN-AUDITED 1st QUARTERLY ...
    Date : 15, Nov 2018
    ORION INFUSION LIMITED Register Office: Orion House...
  • UN-AUDITED THIRD QUARTERL ...
    Date : 2, May 2017
          ORION INFUSION LIMITED Regi...
  • Share Bazaar Awareness ...
    Date : 18, Feb 2017
    দেশব্যাপী বিনিয়োগ শিক্ষা কার্যক্রম বাংলাদেশ সিকিউরিটিজ অ্যা...
  • Share Bazaar Awareness ...
    Date : 16, Feb 2017
    দেশব্যাপী বিনিয়োগ শিক্ষা কার্যক্রমবাংলাদেশ সিকিউরিটিজ অ্যান্...
  • UN-AUDITED HALF YEARLY (Q ...
    Date : 1, Feb 2017
    ORION INFUSION LIMITED Register Office: Orion House, 153-15...

Latest Reports

All News » Price Sensitive Information

  • Date : 1, Jul 2021

     


    ORION INFUSION LIMITED

    Registered Office: Orion House, 153-154 Tejgaon I/A,

    Tejgaon, Dhaka-1208

     

     

    UN-AUDITED THIRD QUARTERLY (Q3)  FINANCIAL STATEMENTS

     

    This is for the information of all concerned that the un-audited condensed consolidated financial statements of Orion Infusion Limited as on and for the Third Quarterly (Q3) period ended on March 31, 2021, has been adopted by the Board of Directors in its meeting held on June 30, 2021. The excerpts of the Financial Statements are as follows:

     

     

     

    March 31, 2021

    March 31, 2020

    NAV per Share – Q3

    :

    BDT.  12.95

    BDT.  12.60

     

     

    July 01, 2020 to March 31, 2021

    July 01, 2019 to March 31, 2020

    Jan 01, 2021 to March 31, 2021

    Jan 01, 2020 to March 31, 2020

    Earnings Per Share (EPS)- Q3

    :

    BDT. 1.12

    BDT. 1.38

    BDT. 0.33

    BDT. 0.24

    Net Operating Cash Flow Per Share (NOCFPS) – Q3

    :

    BDT.  0.53

    BDT.  2.77

    -----

    -----

     

    The Detailed Financial Statements are also available in the Company’s website: www.orioninfusion.com.

     

                                                   

    Company Secretary                                      Chief Financial Officer                  Director

     

    Dated: Dhaka                                    

    June 30, 2021                                                 Managing Director                      Chairman